Germany C-reactive Protein Testing Market Insight
Published: 19 May 2026 | Report Format: Electronic (PDF)
The rise in Germany's preventive medicine care, cardiovascular disease risk assessment, and decentralized diagnostics opens up promising possibilities in the development of high sensitivity and point-of-care CRP tests.
Germany C-reactive Protein Testing Market Insights and Forecasts to 2035
- In 2025, the Germany C-reactive Protein Testing Market stood at USD 254.5 Million, establishing a strong base for future growth.
- It is anticipated to expand at a CAGR of 3.2% over 2025 to 2035, supported by inflammation diagnostics trend.
- The market is projected to reach USD 349.0 Million by 2035, reflecting continuous long-term growth.
Notable Insights for the Germany C-reactive Protein Testing Market
- By bandwidth type, high sensitivity CRP dominates the market, accounting for approximately 42-46% share in 2025. owing to its growing significance in the determination of heart disease risks.
- By product type, point-of-care CRP testing was the fastest segment with an estimated 5.4 % CAGR 2025. led by the rising need for quick, point-of-care detection of inflammatory markers.
- Siemens Healthineers AG spends about €1.5–1.7 billion (USD 1.7-2.0 billion) per year on research and development activities relating to diagnostic systems, immunoassays, and laboratory automation.
Download the eBook (ToC)
- In fiscal 2025, Siemens Healthineers AG recorded revenues of about €22.4 billion (USD 26.0 billion).
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Germany C-reactive protein testing market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Germany C-reactive Protein Testing Market
- Siemens Healthineers AG
- Roche Diagnostics Deutschland GmbH
- Abbott GmbH
- Merck KGaA
- HORIBA Europe GmbH
- Randox Laboratories Germany
- Boditech Med Deutschland
- Aidian GmbH
- Danaher Germany
- Thermo Fisher Scientific Germany
Recent Developments:
- In November 2024HORIBA Europe GmbH extended its European collaboration with GeodAIsics in providing AI-powered sepsis diagnosis systems using CRP-enabled analyzers
Market Segmentation:
Germany C-reactive Protein Testing Market, By Detection Range
- High-Sensitivity CRP (hs-CRP)
- Conventional CRP
- Standard Quantitative CRP
Germany C-reactive Protein Testing Market, By Product Type
- Central Laboratory Testing
- Point-of-Care Testing
- Reagent Kits & Calibrators
Germany C-reactive Protein Testing Market, By End User
- Hospitals & Acute Care Facilities
- Diagnostic Laboratories
- Physician Office Laboratories
Expert Views:
The Germany CRP testing market will grow at a steady pace, driven by preventive screening tests and inflammation diagnostic tests. The market is dominated by hs-CRP tests and hospital tests.
Author: Govind and Krishna By Spherical Insights and Consulting